Electrical device for welding human tissue approved for surgical
use in Russia
12 July 2007 Corpus Christi, Texas, USA. Ukranian company International
Association Welding (IAW) has adapted welding technology to bond human
tissue in surgery. The device has been tested in over 7000 surgical
operations in the Ukraine and has now been approved for use in Russia,
giving the go-ahead for commercial production. The device bonds and
reconnects living soft biological tissue through fusion without the use of
materials such as sutures, staples, sealant or glue. CSMG Technologies, Inc., (OTC
Bulletin Board: CTUM) a technology management company that invested in the
technology, has announced that the
Russian Federal Service of Health Care and Social Development has approved
the tissue welding electro surgery generator and eight instruments for
commercial use in its hospitals and clinics.
CSMG owns the technology and exclusive world rights to the live tissue
bonding device through Live Tissue Connect, Inc. (LTC), a subsidiary corporation
formed for the development and exploitation of the platform technology. Donald S. Robbins, President and CEO
of CSMG said, “This is an achievement of monumental proportions for IAW and CSMG. We
expect to immediately begin implementing our plans with IAW to manufacture,
market and distribute the tissue welding electrosurgery device and hand
instruments in both Ukraine and Russia.
"Russia and Ukraine have a combined
population of about 200 million people with rich industrial, natural and
scientific resources. A world class team of surgeons, scientists, patent
authors and engineers are working on the technology at the E.O. Paton
Institute of Electric Welding in Kiev, Ukraine.
"We believe sales in Russia and Ukraine
could reach $7 to $10 million in 2008 and could grow at a rate of as much as
50% per year for the next several years in these two rapidly expanding
medical markets,” said Donald S. Robbins, President and CEO." “Russian clinical work was performed by
surgeons at Hospital #1 in Moscow and Povlov University Hospital in St.
Petersburg, Russia. We were only able to bring the live tissue welding
technology from an idea stage to its current level of a unique and
revolutionary surgical product because of the R&D funding and support
provided by our long time partner CSMG Technologies,” said Dr. Alexander T Zeluichenko, Director of the
International Association Welding, Kiev, Ukraine. “Welding technologies are victoriously walking around the earth, underwater
and in space. Nowadays welding is being successfully used in medicine for
bonding damaged human tissue and restoring physiological function of human
organs,” says academician BE Paton, EO Paton Institute of Electric
Welding, President of the National Academy of Science, Kiev, Ukraine. LTC
expects to complete the commercial hand instruments, electrocautery
generator and other electrosurgery components for the tissue welding system
and begin product distribution with IAW in the 4th quarter of 2007 for the
Russian and Ukrainian markets now that all necessary approvals have been
received in these countries. Surgeons at 27 Ukraine hospitals and clinics are using the tissue
welding/bonding technology in clinical trials. They have completed more than
7,000 human surgeries using more than 80 types of open and laparoscopic
surgical procedures, demonstrating the technology is universal in its
ability to repair soft biological tissue. These surgeries included lung,
neuro-surgery, nasal septum, intestine, stomach, skin, gall bladder, liver,
spleen, blood vessels, nerves, alba linea, uterus, bladder, gynecological,
fallopian tube, ovary and testicles and dura-matter. Cosmetic surgeries
conducted with this technology include breast reduction, breast implants,
mastopexy and abdominoplasty. The procedure involves little or no scarring,
while restoring the normal function of the body organ or tissue.
The technology was invented and developed at the internationally renowned
E.O. Paton Institute of Electric Welding, National Academy of Sciences of
Ukraine, Kiev, Ukraine, headed by Professor B.E. Paton. U.S., Australian,
Canadian and European Union patents have been issued, and additional U.S.
and foreign patents are pending, all owned by LTC. To top
|
